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Background: Compression therapy is the most widely used treatment for venous leg ulcers and it was used in different
forms for more than 400 years. Published healing rates of venous ulcers obtained with compression therapy vary widely
from 40-95%. According to numerous studies, it has been suggested that the application of external pressure to the calf
muscle raises the interstitial pressure resulting in improved venous return and reduction in the venous hypertension.
Several risk factors have been identified to be correlated with the failure of venous leg ulcers to heal with compression
therapy (longer ulcer duration; large surface area; fibrinous deposition present on >50% of the wound surface and an
Ankle Brachial Pressure Index (ABPI) of <0.85.
Methods:An open prospective single-center study was performed in order to determine possible risk factors associated with
the failure of venous ulcers to heal when treated withmulti-layer high compression bandaging system for 52 weeks. In the
study, 189 patients (101 women, 88 men; mean age 61 years) with venous leg ulcers (ulcer surface >5 cm2; duration >3
months) were included. The study excluded patients with arterial disease (ABPI <0.8), heart insufficiency with ejection
fraction (EF) <35, pregnancy, cancer disease, rheumatoid arthritis, and diabetes. Based on clinical opinion and available
literature, the following were considered as potential risk factors: sex, age, ulceration surface, time since ulcer onset,
previous operations, history of deep vein thrombosis, body mass index (BMI), reduction in calf circumference >3 cm
during the first 50 days of treatment, walking distance during the day<200 meters, calf:ankle circumference ratio<1.3,
fixed ankle joint, history of surgical wound debridement,>50% of wound covered with fibrin, depth of the wound>2 cm.
Results: Within 52 weeks of limb-compression therapy, 24 (12.7%) venous ulcers had failed to heal. A small ulceration
surface (<20 cm2), the duration of the venous ulcer<12 months, a decrease in calf circumference of more than 3 cm, and
emergence of new skin islets on >10% of wound surface during the first 50 days of treatment were favorable prognostic
factors for ulcer healing. A large BMI (>33 kg/m2), short walking distance during the day (<200m), a history of wound
debridement, and ulcers with deepest presentation (>2 cm) were indicators of slow healing. Calf:ankle circumference
ratio <1.3, fixed ankle joint, and reduced ankle range of motion were the only independent parameters associated with
non-healing (P < .001).
Conclusion: The results obtained in this study suggest that non-healing venous ulcers are related to the impairment of the
calf muscle pump. (J Vasc Surg 2009;49:1242-7.)Chronic venous insufficiency and venous leg ulcers are
a major health problem because of their high prevalence
and associated high cost of care. Compression therapy is the
most widely used treatment for venous leg ulcers and it was
used in different forms for more than 400 years.1 The
mechanism of action of compression therapy in the treat-
ment of venous leg ulcers is not completely understood.
According to numerous studies, it has been suggested that
the application of external pressure to the calf muscle raises
the interstitial pressure resulting in improved venous return
and reduction in the venous hypertension.2,3 Published
healing rates of venous ulcers obtained with compression
therapy vary widely from 40-95%.4-10 Several risk factors
have been identified to be correlated with the failure of
venous leg ulcers to heal with compression therapy (longer
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1242ulcer duration, large surface area, fibrinous deposition
present on 50% of the wound surface, and an Ankle
Brachial Pressure Index [ABPI] of 0.85).11
The purpose of this study was to identify possible risk
factors related to the failure of venous leg ulcers to heal with
compression treatment.
METHODS
An open prospective single-center study was performed
in order to determine possible risk factors associated with
the failure of venous ulcers to heal when treated with
multi-layer high compression bandaging system for 52
weeks.
Patients aged at least 16-years-old with leg ulceration
of venous etiology were screened for inclusion in the trial.
Before inclusion in the study, all patients underwent color
duplex scan examination (CDS) and ABPI measurements.
CDS examinations were performed using Siemens Sonoline
Sienna (Erlangen, Germany) ultrasonography scan device
with a 7 MHz probe. Venous compressibility and flow
characteristics were the key elements to exclude thrombo-
sis. The direction of flow was assessed in a 20-30° reverse
Trendelenburg position during Valsalva maneuver. A cuff
inflation-deflation method with rapid cuff deflation in the
JOURNAL OF VASCULAR SURGERY
Volume 49, Number 5 Milic et al 1243standing position was performed to induce reflux. The
presence of reflux was determined by the direction of flow
(significant flow toward the feet was suggestive of reflux). A
reflux time of0.5 seconds has been used to diagnosis the
presence of reflux.
The study excluded patients with an ABPI 0.8 (27
patients), patients with heart insufficiency with an ejection
fraction (EF) 35 (1 patient), pregnancy (1 patient), can-
cer disease (3 patients), rheumatoid arthritis (2 patients),
and diabetes (11 patients). Thirteen patients with uniden-
tified cause of leg ulcer were also excluded from the study.
Only patients with verified venous ulcers (ulcer surface 5
cm2; duration 3 months) were included in the study.
Wound size was determined by measurement (maximal
length and width) as well as by computerized process
consists of mapping the two-dimensional digital image
onto the polygonal mesh. The margins of a wound were
outlined on a computer screen and the enclosed wound
area was automatically determined. Digital images were
taken with the Sony Cyber Shot (Kohda, Japan) digital
camera T10. The digital image included a 5 cm-long cali-
bration marker positioned below the wound surface. The
wound area was evaluated every 15 days.
Two hundred fifty-eight patients were considered for
the study and 200 were included. Eleven patients were lost
during the study and 189 patients (101 women, 88 men;
mean age 61 years) with venous leg ulcers completed the
study. Based on clinical opinion and available literature, the
following were considered as potential risk factors: sex, age
(years), ulceration surface (cm2), time since ulcer onset
(months), previous operations (stripping, superficial endo-
scopic perforator vein surgery [SEPS]), history of deep vein
thrombosis, body mass index (BMI), reduction in calf
circumference3 cm during the first 50 days of treatment,
walking distance 200 meters during the day, calf:ankle
Table I. Demographic and clinical characteristics of patien
Characteristic
Healed by week 26
(n  95)
Hea
Ulceration surface 20 cm2 24 (25)
Wound duration 12 months 31 (33)
Female gender 51 (54)
Age (years) 61.4  9.4
Previous operations 38 (40)
Deep vein thrombosis 38 (40)
BMI 35 11 (12)
Reduction in calf circumference 73 (77)
Daily walking distance 200 m 5 (5)
Calf:ankle circumference ratio 1.3 10 (10)
Fixed ankle joint and ROM 20° 5 (5)
Ulcer recurrence 95 (100)
Wound debrided surgically 11 (12)
Wound covered with fibrin 50% 11 (12)
Lipodermatosclerosis 84 (88)
Depth of the wound 2 cm 8 (8)
Emergence of new skin islets 29 (30)
Values are given as number (percent) or mean  SD.
BMI, Body mass index; ROM, range of motion; SD, standard deviation.circumference (CAC) ratio 1.3, fixed ankle joint andreduced ankle range of motion (ROM) (20°), ulcer re-
currence, history of surgical wound debridement,50% of
wound covered with fibrin, depth of the wound 2 cm,
and emergence of new skin islets on more than 10% of ulcer
surface during the first 50 days of treatment.
Time since ulcer onset, previous operations, history of
surgical wound debridement, and history of deep vein
thrombosis (DVT) were determined according to medical
documentation. The BMI was calculated at the beginning
of the treatment. The depth of the wound was measured
using a cotton-tipped applicator that was inserted into the
deepest portion of the wound. The applicator was marked
with the pen at skin level and the distance was measured
from the tip to the mark. Calf and ankle circumference were
measured in the recumbent position with the maximal
(calf) and minimal (ankle) point determined visually. Calf:
ankle ratio was determined at the beginning of the treat-
ment and afterwards every 30 days. Walking distance dur-
ing the day was determined according to the patient’s daily
activities and patients who had predominantly inactive and
sessile lifestyle were considered to walk less than 200meters
per day. The wound surface covered with fibrin and surface
of new skin islets were determined using a sheet of trans-
parency film that was placed over the wound, and the
boundary of the entire wound and wound surface covered
with fibrin or surface of new skin islets were drawn with a
marking pen on the film. The surfaces were analyzed and
ratio was calculated.
Ankle ROM was determined with the patient in the
supine position by goniometry during maximal voluntary
plantar flexion and dorsiflexion of the ankle. ROM was
determined as the sum of plantar flexion and dorsiflexion.
The study was approved by relevant authorities and
written consent was obtained by all patients included in the
study. The same treatment team comprised of three doctors
y outcome groups
week 27 to
 70) P
Total healed
(n  165)
Not healed
(n  24) P
(67) .001 71 (43) 13 (54) .306
(70) .001 80 (48) 14 (58) .368
(53) .916 88 (53) 13 (54) .939
 10.6 .995 61.4  9.9 61.4  9.3 .991
(47) .361 71 (43) 10 (42) .900
(30) .187 59 (36) 9 (37) .868
(27) .011 30 (18) 3 (12) .773
(53) .001 110 (67) 12 (50) .112
(17) .013 17 (10) 2 (8) .765
(17) .218 22 (13) 18 (75) .001
(10) .248 12 (7) 16 (67) .001
(100) — 165 (100) 24 (100) —
(26) .019 29 (18) 3 (12) .771
(49) .001 45 (27) 8 (33) .538
(87) .804 145 (88) 24 (100) .082
(29) .001 28 (17) 5 (21) .577
(13) .008 38 (23) 2 (8) .100ts b
led by
52 (n
47
49
37
61.4
33
21
19
37
12
12
7
70
18
34
61
20
9and three medical nurses treated all patients. The patients
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Centre of Nis (Serbia) on an ambulatory basis with the
primary endpoint of the study being complete ulcer healing
at 26 and 52 weeks. After ulcer healing, patients were
instructed to continue to wear Tubulcus elastic stockings
(35 mm Hg, Laboratoires Innothera, Arcueil, France) in
order to avoid recurrence. During the treatment, patients
were monitored by the study team at least once a week.
Treatment regimen. The standard regimen was to
debride the wound. This was a normally simple mechanical
debridement with sterile gauze in order to remove slough
and other dead tissue. According to the extent of the
wound, exudation dressings were changed from 1 to 7
days. Extensive wound exudation was treated with crystal
acidum boricum (after debridement, acidum boricum was
applied over the wound in a thin layer) and in patients with
no exudation, dry dressings were performed. No antibiotics
were used and patients in both groups received only aspirin
(100 mg). After wound debridement and dressing bandag-
ing systems were applied, the bandaging systemwas applied
as follows:
- First and second layer were cotton gauze without tension
(50% overlap) and cotton crepe bandage.
- Third layer in the treatment group consisted of ready-
made tubular compression device (Tubulcus) that ex-
erts graduated pressure with the highest compression
(30-40 mm Hg) at the ankle, diminishing up the calf,
and corresponds to class III compression stockings. It is
open-toed and has no heel. Because it is a tubular,
knitted, ready-made device, the appropriate pressure is
exerted regardless of the fitter’s skill. Tubulcus can be
reused and laundered at 60°C. Device size was deter-
mined for each patient according to the circumferences
of the leg measured at the ankle and the largest part of
the calf (5 sizes - S, M, L, XL, and XXL - were
available). The circumference of the limb was measured
every 4 weeks during the treatment and according to
these measurements a new pair of Tubulcus was ap-
plied. If the measurements of the limb stayed in the
initial size, Tubulcus was changed after 6 months.
- The fourth layer was medium-stretch elastic bandage
(100% stretch) 15 cm wide and 5 m long (Niva, Novi
Sad, Serbia) in a spiral with a 50% overlap. The elastic
bandages were applied with the patient in the recum-
bent position and the foot in dorsal flexion. One pair of
elastic bandages was changed regularly every 3 months.
The patient was advised to walk 30 minutes after
bandaging.
The bandaging systems were worn day and night. Al-
though compliance was not formally assessed, there were
no withdrawals from the study because of noncompliance.
Endpoints and statistical analyses. Primary end-
point of the study was complete ulcer healing at 26 and 52
weeks. In cases where the original ulcer closed but a new
area developed on the same limb while the original ulcer
was still present, the limb was considered to be open until
this new area of ulceration had also closed. The definition ofulcer closure was the point at which complete epithelializa-
tion of the reference limb occurred.
After 52 weeks of treatment, statistical data were col-
lected and analyzed. The patients were classified in 3
groups: (1) patients with unhealed ulcers, (2) patients with
ulcers that healed in less than 26 weeks, and (3) patients
with ulcers that healed from 26 to 52 weeks (Table I).
Analysis of potential risk factors associated with the
failure of a venous leg ulcer to heal with compression
treatment was performed between the patients with healed
and unhealed ulcers (Table II). Also, analysis of risk factors
were performed between the patients with healed ulcers
taking into account time for healing (26 weeks and 26-52
weeks) in order to define possible indicators of slow healing
and favorable prognostic factors for ulcer healing (Table III).
Statistical methods. To assess the magnitude of the
effects of given risk factor, single variable logistic regression
was performed to estimate odds ratios (ORs) with 95%
confidence intervals (CIs). The age was used as continuous,
and all other factors as categorical variables.
Reported P values are for the Wald statistics, calculated
as the estimated regression coefficient divided by its stan-
dard error. To calculate adjusted ORs, multivariate logistic
regression was performed using unconditional Enter
method, where all other risk factors, except the risk factor of
interest, were held constant. Independent-samples t test
was used to compare means between two groups. Mantel-
Haenszel 2 test and Fisher exact test were performed for
the frequencies comparison.
Statistical analyses were conducted using SPSS Version
10.0 software (SPSS Inc, Chicago, Ill).
RESULTS
One hundred eighty-nine patients treated for a venous
leg ulcer completed the study. One hundred one patients
(53.4%) were women, and 88 patients (46.6%) were men.
The mean patient’s age at the first office visit was 61.4 years
(range, 17-84 years). After 52 weeks of limb compression
therapy, 24 ulcers (12.7%) had failed to heal. The healing
rate at 26 and 52 weeks of limb compression therapy was
50.26% and 87.3%, respectively.
The median number of previous episodes of ulceration
was 4.7 (range, 2-11), the median size of the ulcer was 29.3
cm2 (range, 5.0-112.0 cm2), and 83.6% of ulcers were
medial, 13.2% were lateral, 2.1% were circumferential, and
1.1% were a combination. Themedian duration of the ulcer
was 6.2 years (range, 4 months-17 years). Sixty-eight pa-
tients (36%) had previous DVT.
Pain, edema, pigmentation, and lipodermatosclerosis
were present in all 189 patients (100%). Eighty-one pa-
tients (42.9%) had previously undergone some surgical
procedure (stripping of greater saphenous vein [GSV] was
performed in 72 patients (38.1%) and 9 patients (4.8%)
underwent SEPS procedure). Mean time from operation
until inclusion in the study was 8.9 years (range, 20
months–29 years). During the observation period, neither
ge of
ge of
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included in the study. There were no deaths or major
complications during the treatment period.
The CEAP classification was as follows:
(a) Clinical-all included limbs had active ulceration (C6);
(b) Etiologic: 58.7% of the patients had primary chronic
venous insufficiency (CVI) while 41.3% of the patients
were classified as secondary CVI. Secondary etiology
was based on ultrasound scan findings.
(c) Anatomic: perforating vein reflux was documented at
duplex scanning in 90 patients (47.6%). Association of
perforating vein reflux with superficial venous reflux
was noted in 32 patients (16.9%). The combination of
both superficial and deep reflux with perforating vein
reflux was observed in 17 (9%). Deep vein reflux was
noted in 50 patients (26.5%).
(d) Pathophysiologic: the pathophysiology identified was
Table II. Influence of the risk factors on the failure of a v
Risk factor Unadjusted OR (95
Ulceration surface 20 cm2 1.56 (0.66-3.70
Wound duration 12 months 1.49 (0.62-3.54
Female gender 1.03 (0.44-2.44
Age (years) 1.00 (0.96-1.04
Previous operations 0.95 (0.40-2.25
Deep vein thrombosis 1.08 (0.44-2.61
BMI 35 0.64 (0.18-2.29
Reduction in calf circumference 0.50 (0.21-1.18
Daily walking distance 200 m 0.79 (0.17-3.66
Calf:ankle circumference ratio 1.3 19.50 (6.98-54.4
Fixed ankle joint and ROM 20° 25.50 (9.03-71.5
Wound debrided surgically 0.67 (0.19-2.40
Wound covered with fibrin 50% 1.33 (0.53-3.33
Depth of the wound 2 cm 1.29 (0.44-3.74
Emergence of new skin islets 0.30 (0.07-1.35
OR, Odds ratio; CI, confidence interval; BMI, body mass index; ROM, ran
Table III. Influence of the risk factors on the prolonged t
Risk factor Unadjusted OR (95
Ulceration surface 20 cm2 6.04 (3.06-11.9
Wound duration 12 months 4.82 (2.47-9.39
Female gender 0.97 (0.52-1.80
Age (years) 0.99 (0.97-1.03
Previous operations 1.34 (0.92-2.50
Deep vein thrombosis 0.64 (0.33-1.24
BMI 35 2.84 (1.25-6.46
Reduction in calf circumference 0.34 (0.17-0.66
Daily walking distance 200 m 3.72 (1.25-11.1
Calf:ankle circumference ratio 1.3 1.76 (0.66-4.75
Fixed ankle joint and ROM 20° 2.00 (0.61-6.59
Wound debrided surgically 2.64 (1.16-6.04
Wound covered with fibrin 50% 7.21 (3.29-15.8
Depth of the wound 2 cm 4.35 (1.78-10.6
Emergence of new skin islets 0.34 (0.15-0.77
OR, Odds ratio; CI, confidence interval; BMI, body mass index; ROM, ranreflux in all 189 limbs (100%).Risk factors associated with prolonged healing time
and non-healing of venous ulcers using compression
treatment and statistical analysis. To assess the magni-
tude of the effects of given risk factor on prolonged time of
a venous leg ulcer to heal, only data for healed patients were
included in logistic regression models and healed within 26
weeks/healed by week 27 to 52 was set as dichotomous
dependent variable. Unadjusted analyses revealed several
significant associations between failure of wounds to heal
within 26 weeks and the measured risk factors. Ulceration
area greater than 20 cm2,wound duration longer than 12
months, BMI value higher than 33 kg/m2, daily walking
distance shorter than 200meters, history of surgical wound
debridement, 50% of wound surface covered with fibrin,
and depth of the wound greater than 2 cm significantly
increased the odds of not healing within 26 weeks. In
contrast, reduction in calf circumference for more than 3
cm during the first 50 days of treatment and emergence of
s leg ulcer to heal
P Adjusted OR (95% CI) P
.31 1.32 (0.31-5.61) .70
.37 1.92 (0.42-8.71) .40
.94 0.41 (0.10-1.71) .22
.98 1.05 (0.98-1.13) .19
.90 1.38 (0.32-5.85) .66
.87 0.68 (0.17-2.68) .58
.50 1.43 (0.18-11.39) .74
.12 0.96 (0.24-3.86) .96
.76 0.89 (0.09-8.44) .92
.001 42.31 (8.19-218.51) .001
.001 60.09 (10.80-334.44) .001
.54 2.90 (0.42-19.84) .28
.54 0.47 (0.09-2.51) .38
.64 1.59 (0.27-9.40) .61
.12 0.38 (0.04-3.43) .39
motion.
of a venous leg ulcer to heal
P Adjusted OR (95% CI) P
.001 4.43 (1.73-11.34) .002
.001 3.49 (1.34-9.11) .011
.92 0.65 (0.26-1.65) .36
.97 1.03 (0.98-1.08) .27
.36 1.94 (0.77-4.91) .16
.19 0.61 (0.24-1.52) .29
.012 3.85 (1.06-13.94) .04
.001 0.20 (0.07-0.54) .002
.019 1.73 (0.31-9.50) .53
.22 3.17 (0.82-12.27) .09
.25 4.09 (0.71-23.39) .11
.021 1.85 (0.58-5.97) .30
.001 8.89 (2.96-26.73) .001
.001 1.65 (0.46-5.95) .44
.01 0.18 (0.05-0.57) .004
motion.enou
% CI)
)
)
)
)
)
)
)
)
)
7)
9)
)
)
)
)ime
% CI)
4)
)
)
)
)
)
)
)
2)
)
)
)
0)
0)
)new skin islets on more than 10% of wound surface signif-
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age, previous operations, DVT, CAC ratio less than 1.3,
and fixed ankle joint with reduced ankle ROM were not
associated with prolonged time of a venous leg ulcer to
heal. The association between the failure of wounds to heal
within 26 weeks and daily walking distance shorter than
200 meters, surgical wound debridement, and depth of the
wound greater than 2 cm became attenuated after adjust-
ment for other risk factors (Table III).
Unadjusted and adjusted analysis revealed significant
associations between failure of wounds to heal within 1 year
and the CAC ratio less than 1.3 and fixed ankle joint with
reduced ankle ROM. All other risk factors were not associ-
ated with the failure of wounds to heal (Table II).
According to statistical analysis, all examined risk fac-
tors could be classified in four groups:
1. Factors with no influence on ulcer healing (sex, age,
previous operations, ulcer recurrence).
2. Favorable prognostic factors for ulcer healing (ulcer-
ation surface 20 cm2, time since ulcer onset 12
months, reduction in calf circumference 3 cm during
the first 50 days of treatment, and emergence of new
skin islets on more than 10% of ulcer surface).
3. Indicators of slow healing (ulceration surface 20
cm2, time since ulcer onset 12 months, BMI 33
kg/m2, walking distance shorter than 200 meters dur-
ing the day, history of surgical wound debridement,
50% of wound covered with fibrin, depth of the
wound 2 cm).
4. Risk factors associated with non-healing (CAC ratio
1.3, fixed ankle joint, and reduced ROM).
DISCUSSION
The goals of compression therapy in the treatment of
venous leg ulcerations are ulcer healing, reduction of pain
and edema, and prevention of recurrence.12 Published
healing rates of venous ulcers obtained with compression
therapy vary widely from 40-95%.4-10 Unfortunately, a
significant number of venous ulcers remain refractory to
compression treatment. A possible way to predict non-
healing venous leg ulcers is to examine prognostic risk
factors that are consistently found in a number of published
studies (large wound area and wound of long duration).
Patients who possess either or both of these factors are at
risk for not healing.4,13,14 The results of our study do not
support these findings. Large and long lasting ulcers could
be healed although more time is needed. A decrease in
wound size during the first 50 days of treatment is a
favorable prognostic factor for healing. According to some
studies, approximately 50-70% of patients with venous
ulcers and a decrease in wound size during the first month
of compression therapy will be healed after 6 months of
treatment.4
Although some studies15 have shown that younger age
is a favorable prognostic factor for ulcer healing, we could
not prove such a relation.Margolis et al14 found that venous stripping and the
presence of fibrin on more than 50% of the wound surface
were the factors associated with the failure of a venous leg
ulcer to heal. Our study didn’t find any correlation between
surgical procedures and ulcer healing while fibrin on more
than 50% of the wound surface was an indicator of slow
healing.
The most difficult ulcers to treat with compression
therapy showing non-healing tendency in our study were
the ulcers with deepest presentation (2 cm in depth) and
ulcers with history of surgical debridement. The reason for
this is, in our opinion, complete destruction of skin struc-
tures and lack of growth factors present in dermis making
the healing process more difficult. The emergence of new
skin islets on the wound surface, a favorable factor for ulcer
healing in our study, never happened in these patients.
A reduction in calf circumference for more than 3 cm
during the first 50 days of compression treatment was a
favorable factor for fast ulcer healing (26weeks). This was
especially notable for the patients with calf circumference
larger than 40 cm at the beginning of the treatment.
In obese patients, more time is needed for ulcer closure
and high BMI (33 kg/m2) was an indicator of slow
healing. Short walking distance during the day (200
meters) was also an indicator of slow healing. We think that
main reason for this is immobility of these patients and
inactivity of their muscle pump. It may be prudent to
introduce intermittent pneumatic compression in the treat-
ment of these patients in order to stimulate muscle pump
and to improve ulcer healing.
Our study of 1 year of compression treatment is longer
than many other studies and this may be the reason in the
discrepancy of risk factors. If the analysis had been carried
out with non-healing at 6 months of compression treat-
ment, then some risk factors do align with other stud-
ies.4,13,14
The only independent parameters associated with non-
healing of venous ulcers when treated with compression
therapy were CAC ratio 1.3 and fixed ankle joint with
reduced ankle ROM (P  .001).
Fixed ankle joint and reduced ankle ROM is well de-
scribed as a significant factor in venous ulceration develop-
ment. Limited ROMwas significantly correlated to EF and
residual volume fraction measured by air plethysmographic
measurement indicating the importance of calf pump func-
tion in the development of venous ulceration.16 Our study
strongly supports these findings. One of the main contrib-
utors to decreased ankle ROM in patients with CVI is
probably inactivity. Bed rest and prolonged inactivity may
lead to muscle atrophy, contracture, and degenerative joint
disease. Pain with ankle motion could also cause a decrease
in voluntary ankle flexion and extension.16
CAC ratio 1.3 was also an indicator of non-healing
venous ulcers. The vast majority of patients included in our
study (60%) had CAC ratio between the values of 1.6 and
1.9 and over 80% of patients had CAC ratio between the
values of 1.4 and 2.2.
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1.2) were the most difficult to treat.
It is interesting that the healing process was more
difficult also in those patients who developed a low CAC
ratio during the compression treatment (1.2). This could
be an indicator of the patient’s inactivity during the treat-
ment. Also, this could mean that too excessive pressure was
implemented for too long a time leading to calf muscle
atrophy. We think that in this case, compression system
with lower interface pressure values should be imple-
mented.
Our results emphasize the importance of the calf mus-
cle pump in the development of venous ulcers, which is in
concordance with many published studies indicating the
importance of calf muscle pump dysfunction.17-19
CONCLUSION
The results obtained in this study suggest that non-
healing venous ulcers are related to the impairment of the
calf muscle pump. Further trials are necessary to identify the
best treatment options especially for non-healing ulcers.
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